Evidence map›Paper›PMID 36223387›Full record

ArticlePloS one2022

Behavioral and brain anatomical analysis of Foxg1 heterozygous mice.

Kirsty R Erickson, Rebekah Farmer, Jonathan K Merritt, Zeljka Miletic Lanaghan, Mark D Does, Karthik Ramadass, Bennett A Landman, Laurie E Cutting, Jeffrey L Neul

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Multimodal epigenetic changes and altered NEUROD1 chromatin binding in the mouse hippocampus underlie FOXG1 syndrome.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Kirsty R EricksonVanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Rebekah FarmerVanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Jonathan K MerrittDepartment of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Zeljka Miletic LanaghanDepartment of Pharmacology, Vanderbilt University, Nashville, Tennessee, United States of America.ORCID 0000-0003-0974-1860
Mark D DoesDepartment of Electrical Engineering, Vanderbilt University Nashville, Tennessee, United States of America.
Karthik RamadassDepartment of Electrical Engineering, Vanderbilt University Nashville, Tennessee, United States of America.
Bennett A LandmanDepartment of Electrical Engineering, Vanderbilt University Nashville, Tennessee, United States of America.ORCID 0000-0001-5733-2127
Laurie E CuttingVanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Jeffrey L NeulVanderbilt Kennedy Center, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.ORCID 0000-0002-5628-5872
Vanderbilt University · USJohn F. Kennedy Center for the Performing Arts · USVanderbilt University Medical Center · US

Funding

TRAINING IN PHARMACOLOGICAL SCIENCEST32GM007628 · NIGMS · VANDERBILT UNIVERSITY · PI BARNETT, JOEY VICTOR, KAVALALI, EGE T · 1985 to 2022
$11.2M
Overall: Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center at VanderbiltP50HD103537 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jeffrey L Neul · 2020 to 2026
$10.3M
Training in Fundamental NeuroscienceT32MH064913 · NIMH · VANDERBILT UNIVERSITY · PI IHRIE, REBECCA A, WINDER, DANNY G. · 2001 to 2022
$7.6M
Research Project: Sensory and Multisensory Contributions to AutismU54HD083211 · NICHD · VANDERBILT UNIVERSITY MEDICAL CENTER · PI DYKENS, ELISABETH MAY · 2015 to 2019
$7.1M
Program in NeurogenomicsT32MH065215 · NIMH · VANDERBILT UNIVERSITY · PI ROGER J COLBRAN · 2002 to 2026
$6.4M
Neurobehavioral and biochemical outcome measures in Rett syndrome rodent modelsR01HD083181 · NICHD · BAYLOR COLLEGE OF MEDICINE · PI NEUL, JEFFREY L, SAMACO, RODNEY C · 2016 to 2020
$3.0M
NICHD NIH HHS P50 HD103537NICHD NIH HHS R01 HD083181NICHD NIH HHS U54 HD083211NIGMS NIH HHS T32 GM007628NIMH NIH HHS T32 MH064913NIMH NIH HHS T32 MH065215
6 · The paper itself

Abstract

FOXG1 Syndrome (FS) is a devastating neurodevelopmental disorder that is caused by a heterozygous loss-of-function (LOF) mutation of the FOXG1 gene, which encodes a transcriptional regulator important for telencephalic brain development. People with FS have marked developmental delays, impaired ambulation, movement disorders, seizures, and behavior abnormalities including autistic features. Current therapeutic approaches are entirely symptomatic, however the ability to rescue phenotypes in mouse models of other genetic neurodevelopmental disorders such as Rett syndrome, Angelman syndrome, and Phelan-McDermid syndrome by postnatal expression of gene products has led to hope that similar approaches could help modify the disease course in other neurodevelopmental disorders such as FS. While FoxG1 protein function plays a critical role in embryonic brain development, the ongoing adult expression of FoxG1 and behavioral phenotypes that present when FoxG1 function is removed postnatally provides support for opportunity for improvement with postnatal treatment. Here we generated a new mouse allele of Foxg1 that disrupts protein expression and characterized the behavioral and structural brain phenotypes in heterozygous mutant animals. These mutant animals display changes in locomotor behavior, gait, anxiety, social interaction, aggression, and learning and memory compared to littermate controls. Additionally, they have structural brain abnormalities reminiscent of people with FS. This information provides a framework for future studies to evaluate the potential for post-natal expression of FoxG1 to modify the disease course in this severe neurodevelopmental disorder.

Indexed as

Behavior, AnimalBrainForkhead Transcription FactorsNerve Tissue ProteinsRett SyndromeAnimalsHeterozygoteMiceForkhead Transcription FactorsFoxg1 protein, mouseNerve Tissue Proteins

Identifiers

PMID36223387
PMCPMC9555627
OpenAlexW4304758303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.